David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$281M |
| 3 |
Bausch Health
BHC
|
+$244M |
| 4 |
SPDR Gold Trust
GLD
|
+$238M |
| 5 |
Coca-Cola
KO
|
+$206M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$397M |
| 2 |
AGN
Allergan Inc
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$265M |
| 5 |
IBM
IBM
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 10.34% |
| 2 | Technology | 9.79% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Healthcare | 8.68% |
| 5 | Financials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
USG
3326
CALL
DELISTED
Usg
USG
| $267K | ﹤0.01% |
10,000
| – | – |
|
3327
Team
TISI
$110M
| $264K | ﹤0.01% |
678
-755
| -53% | -$289K |
|
|
RKUS
3328
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
| $264K | ﹤0.01% |
20,500
-49,785
| -71% | -$557K |
|
|
CAB
3329
DELISTED
Cabela's Inc
CAB
| $263K | ﹤0.01% |
+4,700
| New | +$260K |
|
|
MRGE
3330
DELISTED
MERGE HEALTHCARE INC COM STK (WI)
MRGE
| $262K | ﹤0.01% |
58,553
-40,389
| -41% | -$169K |
|
3331
AngloGold Ashanti
AU
$62.4B
| $261K | ﹤0.01% |
27,934
-1,274,675
| -98% | -$13.6M |
|
3332
Fox Factory Holding Corp
FOXF
$892M
| $261K | ﹤0.01% |
+17,006
| New | +$262K |
|
|
SGM
3333
DELISTED
Stonegate Mortgage Corporation
SGM
| $261K | ﹤0.01% |
24,078
+4,947
| +26% | +$52K |
|
3334
Avery Dennison
AVY
$13.6B
| $260K | ﹤0.01% |
+4,912
| New | +$260K |
|
3335
Inseego
INSG
$74.4M
| $260K | ﹤0.01% |
5,389
+3,686
| +216% | +$180K |
|
3336
AtriCure
ATRC
$2.48B
| $259K | ﹤0.01% |
12,647
-43,334
| -77% | -$840K |
|
|
MDCO
3337
DELISTED
Medicines Co
MDCO
| $259K | ﹤0.01% |
9,234
-1,008,036
| -99% | -$28.3M |
|
|
SWC
3338
CALL
DELISTED
Stillwater Mining Co
SWC
| $258K | ﹤0.01% |
20,000
-14,900
| -43% | -$206K |
|
|
SWC
3339
PUT
DELISTED
Stillwater Mining Co
SWC
| $258K | ﹤0.01% |
20,000
| – | – |
|
3340
CALL
Metallus
MTUS
$800M
| $257K | ﹤0.01% |
9,700
-2,850
| -23% | -$83.8K |
|
|
LBAI
3341
DELISTED
Lakeland Bancorp Inc
LBAI
| $256K | ﹤0.01% |
22,283
-7,326
| -25% | -$81.8K |
|
|
NGHC
3342
DELISTED
National General Holdings Corp
NGHC
| $256K | ﹤0.01% |
+13,701
| New | +$251K |
|
|
MBLY
3343
DELISTED
Mobileye N.V.
MBLY
| $256K | ﹤0.01% |
6,100
-13,265
| -68% | -$516K |
|
3344
HealthStream
HSTM
$844M
| $254K | ﹤0.01% |
10,075
-52,010
| -84% | -$1.42M |
|
3345
Waterstone Financial
WSBF
$378M
| $254K | ﹤0.01% |
19,800
+3,952
| +25% | +$51K |
|
|
HF
3346
DELISTED
HFF Inc.
HF
| $250K | ﹤0.01% |
+6,672
| New | +$240K |
|
3347
Ardmore Shipping
ASC
$735M
| $248K | ﹤0.01% |
+24,618
| New | +$269K |
|
3348
HSBC
HSBC
$358B
| $247K | ﹤0.01% |
6,567
-153
| -2% | -$5.96K |
|
3349
WSFS Financial
WSFS
$4.01B
| $247K | ﹤0.01% |
9,783
-5,814
| -37% | -$148K |
|
|
CUTR
3350
DELISTED
Cutera, Inc.
CUTR
| $246K | ﹤0.01% |
+19,064
| New | +$249K |
|
Similar funds
David Shaw's Q1 2015 Portfolio in Review
As of Q1 2015, David Shaw held 4,408 positions worth $65.3B, down 16% from $77.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $15B in Q1 2015, closing 828 positions and reducing 1,784 holdings. Its most notable exit was Allergan Inc, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Energy at 10% of assets, up from 8.6% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in SPDR Gold Trust worth $231M.
- David Shaw's largest Q1 2015 buy was SPDR Gold Trust: 2,033,000 shares worth $231M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $345M increase.
- David Shaw's biggest Q1 2015 reduction was LyondellBasell Industries, cutting an estimated $397M.
- David Shaw fully exited Allergan Inc in Q1 2015, selling an estimated $374M.
- David Shaw's ten largest holdings make up 11% of its $65.3B portfolio in Q1 2015.
- David Shaw opened 448 new positions and closed 828 in Q1 2015.
- David Shaw's portfolio value fell 16% quarter-over-quarter to $65.3B.
Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.